V. O. Speights - Concepedia

Author

V. O. Speights

Also Known As

V O SPEIGHTS, V O Speights, V Speights, V. O. SPEIGHTS, V. O. Speights, V.O Speights, V.O. SPEIGHTS, V.O. SPEIGHTS Jr, V.O. Speights, V.O. Speights Jr

Publications

Citations

H-Index

Concepts

All Affiliations

Scott & White Memorial Hospital University of Utah United States Department of Veterans Affairs Cancer Research And Biostatistics Texas A&M University

About

V. O. Speights is an author at Scott & White Memorial Hospital specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	19	658
2	Health Sciences	3	3	96
3	Cell Biology	2	2	76
4	Public Health	1	1	35
5	Biostatistics	1	1	53

V. O. Speights

Publications

5.8K

Citations

H-Index

Page 1

	Year	Citations
Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer H. Barton Grossman, Ronald B. Natale, Catherine M. Tangen, New England Journal of Medicine	2003	2.6K
Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study Jack Cuzick, Gregory P. Swanson, Gabrielle Fisher, The Lancet Oncology	2011	800
Pathologist Workforce in the United States: I. Development of a Predictive Model to Examine Factors Influencing Supply Stanley J. Robboy, Sally Weintraub, Andrew E. Horvath, Archives of Pathology & Laboratory Medicine	2013	213
Quality of pathologic response and surgery correlate with survival for patients with completely resected bladder cancer after neoadjuvant chemotherapy Guru Sonpavde, Bryan Goldman, V. O. Speights, Cancer	2009	195
Stage at presentation and survival of white and black patients with prostate carcinoma Peter N. Brawn, Edwin H. Johnson, Daniel Kuhl, Cancer	1993	151
Cyclooxygenase-2 Regulates Survival, Migration, and Invasion of Human Endometriotic Cells through Multiple Mechanisms Sakhila K. Banu, JeHoon Lee, V. O. Speights, Endocrinology	2007	147
Do mixed histological features affect survival benefit from neoadjuvant platinum‐based combination chemotherapy in patients with locally advanced bladder cancer? A secondary analysis of Southwest Oncology Group‐Directed Intergroup Study (S8710) Emil Scosyrev, Benjamin Ely, Edward M. Messing, British Journal of Urology	2010	142
Hypermethylation of the caveolin‐1 gene promoter in prostate cancer Cui Jiang, L. Ralph Rohr, Gregory P. Swanson, The Prostate	2001	125
Selective Inhibition of Prostaglandin E2 Receptors EP2 and EP4 Induces Apoptosis of Human Endometriotic Cells through Suppression of ERK1/2, AKT, NFκB, and β-Catenin Pathways and Activation of Intrinsic Apoptotic Mechanisms Sakhila K. Banu, JeHoon Lee, V. O. Speights, Molecular Endocrinology	2009	114
Pathology of androgen deprivation therapy in prostate carcinoma. A comparative study of 173 patients Francisco Civantos, Manuel A. Marcial, Evelyn R. Banks, Cancer	1995	109

Page 1